Zentalis Pharmaceuticals, Inc. (ZNTL)
NASDAQ: ZNTL · Real-Time Price · USD
2.390
-0.080 (-3.24%)
At close: Feb 27, 2026, 4:00 PM EST
2.360
-0.030 (-1.26%)
After-hours: Feb 27, 2026, 4:33 PM EST
Zentalis Pharmaceuticals Market Cap
Zentalis Pharmaceuticals has a market cap or net worth of $154.75 million as of February 27, 2026. Its market cap has increased by 4.40% in one year.
Market Cap
154.75M
Enterprise Value
-82.57M
1-Year Change
4.40%
Ranking
Category
Stock Price
$2.39
Market Cap Chart
Since April 3, 2020, Zentalis Pharmaceuticals's market cap has decreased from $587.46M to $154.75M, a decrease of -73.66%. That is a compound annual growth rate of -20.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 26, 2026 | 159.93M | 82.96% |
| Dec 31, 2025 | 87.41M | -59.52% |
| Dec 31, 2024 | 215.93M | -79.86% |
| Dec 29, 2023 | 1.07B | -6.72% |
| Dec 30, 2022 | 1.15B | -69.82% |
| Dec 31, 2021 | 3.81B | 80.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Apr 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Karyopharm Therapeutics | 171.52M |
| Acumen Pharmaceuticals | 171.42M |
| Rani Therapeutics Holdings | 167.70M |
| ProQR Therapeutics | 167.50M |
| Compugen | 167.43M |
| Innate Pharma | 166.27M |
| Sangamo Therapeutics | 163.54M |
| Whitehawk Therapeutics | 153.17M |